PriceTracker GLP-1
Loading the index…

Try

Loading the index…

Try

GLP-1 TV · Patient story · views checked Oct 2026

$HIMS Faces 50% Cheaper GLP-1s

Patient storyMikele X10 Stocks1,241 views12:09Sep 2026

Our summary

According to the video, the US government's own pricing site lists Wegovy at $1,349 per month, while the same site says a cash buyer can pay $349. The creator says that for someone buying with cash, the real drop was from $499 (Novo's cash price as of March 2025) to $349, which he calls smaller than the headline suggests. He explains the "most favored nation" approach and describes agreements reached on November 6, 2025 with Novo Nordisk and Eli Lilly. These cover a Medicare pilot with a $50 co-payment since July 1, the Trump RX cash-price website launched in February, and little change for people with private insurance.

One person's experience, in their words. Not medical advice.

What else the video covers

The creator then looks at what this means for Hims. He says Hims charges the same drug price as Trump RX plus a $149 monthly membership, so a customer could get a prescription elsewhere and save about $149 a month. He also points to Hims moving from compounded drugs to brand-name drugs under an agreement with Novo, a gross margin drop from 76% to 64% in a year, and an FTC lawsuit filed in July, which Hims denies. His counterpoint is that Trump RX is a price and coupon, not a prescriber, so the prescription remains the bottleneck that Hims provides.

In the last part he runs round numbers. With the $149 fee held steady, Hims would keep about 30% of the pen price and about 50% of the pill price. He says CEO Andrew Dudum expects these drugs to fall to $40 to $50 a month. At $45, he calculates Hims would earn $194 per customer, a 77% share. He says revenue per customer could fall while margin rises, and he discusses competitor risk, patient data and possible app features such as wearables as ways to justify the fee.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The creator says the government site lists Wegovy at $1,349 a month versus $349 in cash, and that Hims adds a $149 membership.
  2. 2:02 He describes the November 6, 2025 agreements with Novo Nordisk and Eli Lilly, covering a $50 Medicare co-pay pilot and the Trump RX cash-price site.
  3. 3:33 He says the cash-buyer drop was from $499 to $349, and that a Hims customer could save about $149 a month by getting a prescription elsewhere.
  4. 4:35 He cites Hims' move to brand-name drugs, a gross margin fall from 76% to 64%, and the FTC lawsuit that Hims denies.
  5. 5:07 He argues Trump RX sells a drug but does not prescribe it, so the prescription is the bottleneck Hims serves.
  6. 7:41 He calculates that at $45 a month for the drug, Hims would earn $194 per customer, a 77% share, with lower revenue but higher margin.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 The Hims weight loss model
  2. 0:49 X10 trading products
  3. 2:12 Market shifts in drug pricing
  4. 4:20 Hims' business model challenges
  5. 5:11 The value of the prescription
  6. 6:31 Convenience as a competitive moat
  7. 7:33 Future margin projections
  8. 9:00 Data and future growth

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Wegovy
Prices mentioned
$149 a month, $498 a month and $50 a month
Who is speaking
Patient

Questions this video answers

How much does Wegovy cost with Trump RX?

According to the video, the government's pricing site lists Wegovy at $1,349 a month and says an American can pay $349 in cash. The creator adds that the price depends on the pen, how long you have used it and the dose, and that the pill starts at $149.

How much does Hims charge for Wegovy?

The creator says Hims charges the same drug prices as Trump RX plus a $149 monthly membership. He puts the pen at about $498 a month and the pill at about $300.

Do lower GLP-1 prices hurt Hims?

The creator argues they may not. He says a prescription is still required, and if drug prices fall to $40 to $50 a month, revenue per customer could drop while Hims' share of each dollar rises. He also lists risks, including rivals offering cheaper memberships.

What is the Medicare GLP-1 pilot program?

The creator says that since July 1, a Medicare pilot lets eligible members get these medications for a $50 co-payment. He notes this affects older customers who might otherwise pay Hims' fee.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • TrumpRx GLP-1 prices: what Wegovy, Zepbound, Ozempic and Foundayo cost there

    TrumpRx.gov does not sell GLP-1s. It lists each maker's own cash price and passes you to the maker: a Novo coupon you show at the pharmacy, or LillyDirect for Lilly's drugs. On 8 October 2026 it showed the Wegovy pill at $149 to $299 a month by dose, the Wegovy pen and Ozempic at $199 for two new-patient fills then $349, Zepbound at $299 to $449 and Foundayo at $149 to $299. Those match what NovoCare and LillyDirect publish, and they are cash only.

  • Hims vs Ro: what each GLP-1 membership costs once the drug is added

    As of October 2026, Hims and Ro cost the same if you pay month to month: both charge a $149 monthly membership after a discounted first month, with the drug billed on top at matching starting prices, such as $149 for the Wegovy pill. Ro is cheaper only on its prepaid membership, $74 a month on a 12-month plan ($888 up front), which brings the starting Wegovy pill to $223 a month all in. We partner with neither, and partner programs on our board start lower.

  • The Wegovy coupon: what $25 turns into at the counter

    Novo's Wegovy savings offer advertises as little as $25 a month, and caps the saving at $100. That cap is what decides your number: a $110 copay becomes $25, a $400 copay becomes $300. Government beneficiaries are excluded, so on Medicare or Medicaid the card is closed to you and the Medicare GLP-1 Bridge is the route instead. Without any insurance the card does not apply either, and Novo's own cash price is $349 a month for the pen or from $149 for the tablet.

Find more like it

Dose changeInjection techniqueCost and insurance

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV